CGI B2 The Oaks Oaks Business Park Fordham Road Newmarket Eddisons Cambridge July 2023 scaled

New-build life science and medical facility set to start in Newmarket

06/07/2023

News

A CGI of Building 2, The Oaks, Oaks Business Park, Fordham Road, Newmarket (courtesy of Hamilton Land)

The scene is set for a second new-build medical/life science facility in Cambridgeshire.

Adjacent to GenesisCare’s Oncology Centre at Oaks Business Park in Newmarket, Eddisons advises there can be an immediate start on site - subject to agreement of either freehold or leasehold terms with a buyer or occupier.

The new Class E life science/medical facility - Building 2, The Oaks - is being developed by Hamilton Land and will be the companion building in the scheme to GenesisCare’s Oncology Centre, completed and fitted-out to the occupier’s technical specification by the developer five years ago.

Building 2 is a three storey building with floor space from 685.50 sq m (7,378 sq ft) to 2,057 sq m (22,140 sq ft) - 3D-view laboratory floor layouts of Building 2 are available - and is being offered with on-site parking for 66 cars.

Oaks Business Park is on Fordham Road, Newmarket - a main arterial route to the town centre, off the A14 at Junction 37.

Download the PDF brochure

In addition to GenesisCare, Addenbrooke’s NHS Foundation Trust is a high profile occupier in the sector whose move to the park freed up clinical space at its main hospital site in Cambridge.

According to Eddisons, Newmarket offers a ‘solid,’ complementary location to the more conventional life sciences and lab markets of the Cambridge area, given the Suffolk town’s dual carriage road links via both the A11 & A14.

Ben Green, who is leading Eddisons’ agency of Building 2, The Oaks, explains, “Granta Park, Babraham Research Park and Cambridge Science Park are all accessible, with a drive time of, circa, 20 minutes from Newmarket.

“And a regular train service runs between Newmarket and Cambridge’s central station.

“Accessibility and affordability make Newmarket an increasingly viable option for new or established operators in the medical or life science sectors who are looking for commercial lab or office space.”

For more detailed information about Building 2, The Oaks, Oaks Business Park,Fordham Road, Newmarket, including 3D-view laboratory floor layouts, contact Ben Green at Eddisons in Cambridge, tel 01223 467155, [email protected], learn more, or download the brochure.

Get in touch with the Eddisons team

Please contact us for more details and information

Related reading

View All
New Government firmly links planning reform with growth agenda Liverpool, United Kingdom   October 09 2023 Labour Party Conference  The Shadow Chancellor of the Exchequer, Rachel Reeves announcing the Labour party's financial manifesto for the General Election

News

New Government firmly links planning reform with growth agenda

Read More
Eddisons builds on senior level commercial surveying offer Annette Booker   Associate Director   Eddisons Kettering & Northampton   July 2024

News

Eddisons builds on senior level commercial surveying offer

Read More
Rare Velocette LE 'Noddy bike' to be auctioned after garage discovery Velo

News

Rare Velocette LE 'Noddy bike' to be auctioned after garage discovery

Read More
Eddisons celebrates constructing excellence in the East Midlands 01 Image courtesy of ASI Newark Lincoln College   June 2024

News

Eddisons celebrates constructing excellence in the East Midlands

Read More
View Meet the Team
CTA grid   Our Team

Our team

We're proud to employ more than 450 talented individuals working across a multitude of disciplines.

Find Your Nearest Office
UK Map   Dotted

Office finder

Eddisons is rapidly growing; emphasised by our nationwide network of 30 offices across the UK.

Get In Touch with Eddisons
CTA grid   Contact Us

Contact us

We're ready to take your call and can quickly pass you through to the right department.

Sign Up To Our Newsletter
CTA grid   Newsletter

Newsletter

Join thousands of property managers, occupiers, landlords and investors receiving the latest insights.

This site uses cookies to monitor site performance and provide a more responsive and personalised experience. You must agree to our use of certain cookies. For more information on how we use and manage cookies, please read our Privacy Policy.